|
|
|
|
|
|
|
|
|
|
Maryland
|
|
001-33549
|
|
38-3754322
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
780 Third Avenue, 21
st
Floor
New York, New York
|
|
10017
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
Item 2.02
|
Results of Operations and Financial Condition.
|
Item 2.03
|
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
|
Item 7.01
|
Regulation FD Disclosure.
|
Item 9.01
|
Financial Statements and Exhibits.
|
10.1
|
|
|
|
|
|
|
TIPTREE INC.
|
|
|
|
|
|
Date:
|
May 7, 2018
|
By:
|
/s/ Jonathan Ilany
|
|
|
|
Name: Jonathan Ilany
|
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
Fifth Amendment Incremental Term Lender
|
Fifth Amendment Incremental Term Commitment
|
DBDB Funding LLC
|
$4,000,000
|
Fortress Credit Opportunities VII CLO Limited
|
$8,162,570.37
|
Fortress Credit Opportunities IX CLO Limited
|
$27,023,249.95
|
Fortress Credit Opportunities XI CLO Limited
|
$7,814,079.68
|
Total
|
$47,000,000
|
|
|
|
(i)
|
on or before the first anniversary of the Closing Date, three percent (3.00%);
|
(ii)
|
after the first anniversary of the Closing Date but on or before the second anniversary of the Closing Date, two percent (2.00%); and
|
•
|
Revenues of
$148.1 million
for the quarter, up
1.3%
from
$146.2 million
in the prior year period.
|
•
|
Net income before non-controlling interests
of
$29.0 million
for the quarter, an increase of
$27.7 million
from the prior year period, primarily driven by the gain on sale of Care.
|
•
|
Adjusted EBITDA
1
of
$5.3 million
for the quarter, down
55.1%
from
$11.8 million
in the prior year period. Normalized EBITDA
1
, which removes the impact of realized and unrealized gains and losses and stock-based compensation, of
$8.9 million
for the quarter, compared to
$12.4 million
in 2017.
|
•
|
Book value per share, as exchanged
1
of
$10.59
, up 4.3% compared to
$10.15
as of
March 31, 2017
.
|
•
|
Declared a dividend of $0.035 per share, up 16.7% to stockholders of record on
May 21, 2018
with a payment date of
May 29, 2018
.
|
($ in millions, except for per share information)
|
Three Months Ended March 31,
|
|
||||||
GAAP:
|
2018
|
|
2017
|
|
||||
Total revenues
|
$
|
148.1
|
|
|
$
|
146.2
|
|
|
Net income before non-controlling interests
|
$
|
29.0
|
|
|
$
|
1.3
|
|
|
Net income attributable to Tiptree Inc. Class A common stockholders
|
$
|
23.6
|
|
|
$
|
1.1
|
|
|
Diluted earnings per share
|
$
|
0.79
|
|
|
$
|
0.03
|
|
|
|
|
|
|
|
||||
Non-GAAP:
(1)
|
|
|
|
|
||||
Adjusted EBITDA
|
$
|
5.3
|
|
|
$
|
11.8
|
|
|
Normalized EBITDA
|
$
|
8.9
|
|
|
$
|
12.4
|
|
|
Book value per share, as exchanged
|
$
|
10.59
|
|
|
$
|
10.15
|
|
|
•
|
Specialty Insurance operations continued to grow as gross written premiums were $201 million, up 21.3%, driven by growth across all our product lines. Net written premiums were $109 million, up 26.5%, driven by a combination of premium growth and increased retention rates.
|
•
|
On March 28, 2018, we expanded our insurance operations into Europe with the creation of Fortegra Europe Insurance Company Limited (“FEIC”).
|
•
|
On February 1, 2018, we sold our senior living operations to Invesque in exchange for a net 16.4 million shares, which was $0.91 accretive to our book value per share, as exchanged, or a 9.1% increase over our December 31, 2017 book value per share, as exchanged.
|
•
|
On March 23, 2018, we initiated an up to $20 million share buy-back plan split evenly between open market and opportunistic large block purchases.
|
•
|
On April 10, 2018, we completed a corporate reorganization that eliminated our dual class stock structure.
|
•
|
On May 4, 2018, we extended our existing credit facility to September 2020 and up-sized to $75 million while reducing the interest rate by 100 basis points. Combined with corporate cash, this gives us approximately $100 million of capital available to invest in support of our growth objectives.
|
($ in thousands)
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Unrealized & realized gains (losses) on equity securities
(1)
|
$
|
(8,697
|
)
|
|
$
|
(1,740
|
)
|
Discontinued operations (Care)
(2)
|
$
|
46,808
|
|
|
$
|
(1,530
|
)
|
Asset management - credit investments
|
$
|
277
|
|
|
$
|
5,168
|
|
($ in thousands)
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Specialty Insurance
|
$
|
1,343
|
|
|
$
|
4,801
|
|
Tiptree Capital:
|
|
|
|
||||
Asset management
|
892
|
|
|
5,581
|
|
||
Mortgage
|
153
|
|
|
301
|
|
||
Other
|
(2,717
|
)
|
|
84
|
|
||
Corporate
|
(6,714
|
)
|
|
(6,729
|
)
|
||
Pre-tax income (loss) from continuing operations
|
$
|
(7,043
|
)
|
|
$
|
4,038
|
|
Pre-tax income (loss) from discontinued operations
(1)
|
$
|
46,808
|
|
|
$
|
(1,530
|
)
|
(1)
|
Includes Care for 2017 and 2018. Includes $
46.2 million
pre-tax gain on sale of Care in 2018.
|
($ in thousands)
|
Three Months Ended March 31,
|
||||||||||||||
|
Total Capital
|
|
Adjusted EBITDA
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Specialty Insurance
|
$
|
441,518
|
|
|
$
|
402,252
|
|
|
$
|
8,193
|
|
|
$
|
9,379
|
|
Tiptree Capital
|
147,244
|
|
|
190,752
|
|
|
5,505
|
|
|
9,530
|
|
||||
Asset management
|
4,164
|
|
|
38,474
|
|
|
892
|
|
|
5,581
|
|
||||
Mortgage
|
30,890
|
|
|
25,291
|
|
|
289
|
|
|
839
|
|
||||
Other
(2)
|
112,190
|
|
|
126,987
|
|
|
4,324
|
|
|
3,110
|
|
||||
Corporate
|
43,228
|
|
|
45,507
|
|
|
(8,354
|
)
|
|
(7,123
|
)
|
||||
Total Tiptree
|
$
|
631,990
|
|
|
$
|
638,511
|
|
|
$
|
5,344
|
|
|
$
|
11,786
|
|
(1)
|
For further information relating to the Company’s Total Capital and Adjusted EBITDA, including a reconciliation to GAAP total stockholders equity and pre-tax income, see “—Non-GAAP Reconciliations.”
|
(2)
|
Includes discontinued operations related to Care. As of February 1, 2018, invested capital from Care discontinued operations is represented by our investment in Invesque common shares. For more information, see Note—
(3) Dispositions, Assets Held for Sale & Discontinued Operations
, in the Form 10-Q for the quarter ended March 31, 2018.
|
|
As of
|
||||||
|
March 31, 2018
|
|
December 31, 2017
|
||||
Assets:
|
|
|
|
||||
Investments:
|
|
|
|
|
|||
Available for sale securities, at fair value
|
$
|
212,809
|
|
|
$
|
182,448
|
|
Loans, at fair value
|
239,331
|
|
|
258,173
|
|
||
Equity securities, at fair value
|
140,238
|
|
|
25,536
|
|
||
Other investments
|
41,243
|
|
|
59,142
|
|
||
Total investments
|
633,621
|
|
|
525,299
|
|
||
Cash and cash equivalents
|
81,219
|
|
|
110,667
|
|
||
Restricted cash
|
19,336
|
|
|
31,570
|
|
||
Notes and accounts receivable, net
|
201,157
|
|
|
186,422
|
|
||
Reinsurance receivables
|
362,411
|
|
|
352,967
|
|
||
Deferred acquisition costs
|
143,146
|
|
|
147,162
|
|
||
Goodwill
|
91,562
|
|
|
91,562
|
|
||
Intangible assets, net
|
59,375
|
|
|
64,017
|
|
||
Other assets
|
42,122
|
|
|
31,584
|
|
||
Assets held for sale
|
54,857
|
|
|
448,492
|
|
||
Total assets
|
$
|
1,688,806
|
|
|
$
|
1,989,742
|
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity
|
|
|
|
||||
Liabilities:
|
|
|
|
||||
Debt, net
|
$
|
320,508
|
|
|
$
|
346,081
|
|
Unearned premiums
|
521,085
|
|
|
503,446
|
|
||
Policy liabilities and unpaid claims
|
117,740
|
|
|
112,003
|
|
||
Deferred revenue
|
58,349
|
|
|
56,745
|
|
||
Reinsurance payable
|
96,178
|
|
|
90,554
|
|
||
Other liabilities and accrued expenses
|
117,818
|
|
|
121,321
|
|
||
Liabilities held for sale
|
49,468
|
|
|
362,818
|
|
||
Total liabilities
|
$
|
1,281,146
|
|
|
$
|
1,592,968
|
|
|
|
|
|
||||
Stockholders’ Equity:
|
|
|
|
||||
Preferred stock: $0.001 par value, 100,000,000 shares authorized, none issued or outstanding
|
$
|
—
|
|
|
$
|
—
|
|
Common stock - Class A: $0.001 par value, 200,000,000 shares authorized, 35,003,004 and 35,003,004 shares issued and outstanding, respectively
|
35
|
|
|
35
|
|
||
Common stock - Class B: $0.001 par value, 50,000,000 shares authorized, 8,049,029 and 8,049,029 shares issued and outstanding, respectively
|
8
|
|
|
8
|
|
||
Additional paid-in capital
|
294,678
|
|
|
295,582
|
|
||
Accumulated other comprehensive income (loss), net of tax
|
(1,483
|
)
|
|
966
|
|
||
Retained earnings
|
60,741
|
|
|
38,079
|
|
||
Class A common stock held by subsidiaries, 5,080,943 and 5,197,551 shares, respectively
|
(33,823
|
)
|
|
(34,585
|
)
|
||
Class B common stock held by subsidiaries, 8,049,029 and 8,049,029 shares, respectively
|
(8
|
)
|
|
(8
|
)
|
||
Total Tiptree Inc. stockholders’ equity
|
320,148
|
|
|
300,077
|
|
||
Non-controlling interests - TFP
|
82,082
|
|
|
77,494
|
|
||
Non-controlling interests - Other
|
5,430
|
|
|
19,203
|
|
||
Total stockholders’ equity
|
407,660
|
|
|
396,774
|
|
||
Total liabilities and stockholders’ equity
|
$
|
1,688,806
|
|
|
$
|
1,989,742
|
|
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Revenues:
|
|
|
|
||||
Earned premiums, net
|
$
|
101,645
|
|
|
$
|
89,231
|
|
Service and administrative fees
|
24,576
|
|
|
23,776
|
|
||
Ceding commissions
|
2,283
|
|
|
2,271
|
|
||
Net investment income
|
4,205
|
|
|
4,505
|
|
||
Net realized and unrealized gains (losses)
|
6,606
|
|
|
16,212
|
|
||
Other revenue
|
8,757
|
|
|
10,194
|
|
||
Total revenues
|
148,072
|
|
|
146,189
|
|
||
Expenses:
|
|
|
|
||||
Policy and contract benefits
|
36,626
|
|
|
32,992
|
|
||
Commission expense
|
62,633
|
|
|
56,793
|
|
||
Employee compensation and benefits
|
27,788
|
|
|
29,030
|
|
||
Interest expense
|
5,946
|
|
|
6,078
|
|
||
Depreciation and amortization
|
2,957
|
|
|
3,554
|
|
||
Other expenses
|
19,165
|
|
|
17,619
|
|
||
Total expenses
|
155,115
|
|
|
146,066
|
|
||
Other income:
|
|
|
|
||||
Income attributable to consolidated CLOs
|
—
|
|
|
8,867
|
|
||
Expenses attributable to consolidated CLOs
|
—
|
|
|
4,952
|
|
||
Net income (loss) attributable to consolidated CLOs
|
—
|
|
|
3,915
|
|
||
Total other income
|
—
|
|
|
3,915
|
|
||
Income (loss) before taxes from continuing operations
|
(7,043
|
)
|
|
4,038
|
|
||
Less: provision (benefit) for income taxes
|
(1,568
|
)
|
|
1,568
|
|
||
Net income (loss) from continuing operations
|
(5,475
|
)
|
|
2,470
|
|
||
Discontinued operations:
|
|
|
|
||||
Income (loss) before taxes from discontinued operations
|
624
|
|
|
(1,530
|
)
|
||
Gain on sale of discontinued operations, net
|
46,184
|
|
|
—
|
|
||
Less: Provision (benefit) for income taxes
|
12,327
|
|
|
(402
|
)
|
||
Net income (loss) from discontinued operations
|
34,481
|
|
|
(1,128
|
)
|
||
Net income (loss) before non-controlling interests
|
29,006
|
|
|
1,342
|
|
||
Less: net income (loss) attributable to non-controlling interests - TFP
|
5,392
|
|
|
208
|
|
||
Less: net income (loss) attributable to non-controlling interests - Other
|
54
|
|
|
34
|
|
||
Net income (loss) attributable to Tiptree Inc. Class A common stockholders
|
$
|
23,560
|
|
|
$
|
1,100
|
|
|
|
|
|
||||
Net income (loss) per Class A common share:
|
|
|
|
||||
Basic, continuing operations, net
|
$
|
(0.15
|
)
|
|
$
|
0.07
|
|
Basic, discontinued operations, net
|
0.94
|
|
|
(0.03
|
)
|
||
Basic earnings per share
|
$
|
0.79
|
|
|
$
|
0.04
|
|
|
|
|
|
||||
Diluted, continuing operations, net
|
(0.15
|
)
|
|
0.06
|
|
||
Diluted, discontinued operations, net
|
0.94
|
|
|
(0.03
|
)
|
||
Diluted earnings per share
|
$
|
0.79
|
|
|
$
|
0.03
|
|
|
|
|
|
||||
Weighted average number of Class A common shares:
|
|
|
|
||||
Basic
|
29,861,496
|
|
|
28,424,824
|
|
||
Diluted
|
29,861,496
|
|
|
36,749,956
|
|
||
|
|
|
|
||||
Dividends declared per common share
|
$
|
0.035
|
|
|
$
|
0.030
|
|
($ in thousands)
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Net income (loss) available to Class A common stockholders
|
$
|
23,560
|
|
|
$
|
1,100
|
|
Add: net (loss) income attributable to noncontrolling interests
|
5,446
|
|
|
242
|
|
||
Less: net income from discontinued operations
|
34,481
|
|
|
(1,128
|
)
|
||
Income (loss) from continuing operations
|
$
|
(5,475
|
)
|
|
$
|
2,470
|
|
Consolidated interest expense
|
5,946
|
|
|
6,078
|
|
||
Consolidated income tax expense (benefit)
|
(1,568
|
)
|
|
1,568
|
|
||
Consolidated depreciation and amortization expense
|
2,957
|
|
|
3,554
|
|
||
EBITDA from Continuing Operations
|
$
|
1,860
|
|
|
$
|
13,670
|
|
Asset-based interest expense
(1)
|
(2,094
|
)
|
|
(3,163
|
)
|
||
Effects of purchase accounting
(2)
|
(248
|
)
|
|
(464
|
)
|
||
Non-cash fair value adjustments
(3)
|
66
|
|
|
513
|
|
||
Non-recurring expenses
(4)
|
(376
|
)
|
|
(1,736
|
)
|
||
Adjusted EBITDA from Continuing Operations
|
$
|
(792
|
)
|
|
$
|
8,820
|
|
|
|
|
|
||||
Income (loss) from discontinued operations
|
$
|
34,481
|
|
|
$
|
(1,128
|
)
|
Consolidated interest expense
|
1,252
|
|
|
2,701
|
|
||
Consolidated income tax expense (benefit)
|
12,327
|
|
|
(402
|
)
|
||
Consolidated depreciation and amortization expense
|
—
|
|
|
4,255
|
|
||
EBITDA from discontinued operations
|
$
|
48,060
|
|
|
$
|
5,426
|
|
Asset based interest expense
(1)
|
(1,252
|
)
|
|
(2,701
|
)
|
||
Non-cash fair value adjustments
(3)
|
(40,672
|
)
|
|
—
|
|
||
Non-recurring expenses
(4)
|
—
|
|
|
241
|
|
||
Adjusted EBITDA from discontinued operations
|
$
|
6,136
|
|
|
$
|
2,966
|
|
Total Adjusted EBITDA
|
$
|
5,344
|
|
|
$
|
11,786
|
|
(1)
|
The consolidated asset-based interest expense is subtracted from EBITDA to arrive at Adjusted EBITDA. This includes interest expense associated with asset-specific debt at subsidiaries in the specialty insurance, asset management, mortgage and other operations.
|
(2)
|
Following the purchase accounting adjustments, current period expenses associated with deferred costs were more favorably stated and current period income associated with deferred revenues were less favorably stated. Thus, the purchase accounting effect related to Fortegra increased EBITDA above what the historical basis of accounting would have generated. The impact of this purchase accounting adjustments have been reversed to reflect an adjusted EBITDA without such purchase accounting effect.
|
(3)
|
For Reliance, within our mortgage operations, Adjusted EBITDA excludes the impact of changes in contingent earn-outs. For our specialty insurance operations, depreciation and amortization on senior living real estate that is within net investment income is added back to Adjusted EBITDA. For Care (Discontinued Operations), the reduction in EBITDA is related to accumulated depreciation and amortization, and certain operating expenses, which were previously included in Adjusted EBITDA in prior periods.
|
(4)
|
Acquisition, start-up and disposition costs including legal, taxes, banker fees and other costs. Also includes payments pursuant to a separation agreement, dated as of November 10, 2015.
|
|
Three Months Ended March 31, 2018
|
||||||||||||||||||||||||||||||
|
|
|
Tiptree Capital
|
|
|
|
|
||||||||||||||||||||||||
($ in thousands)
|
Specialty insurance
|
|
Asset Management
|
|
Mortgage
|
|
Other
|
|
Discontinued Operations
(1)
|
|
Tiptree Capital
|
|
Corporate Expenses
|
|
Total
|
||||||||||||||||
Pre-tax income/(loss) from continuing ops
|
$
|
1,343
|
|
|
$
|
892
|
|
|
$
|
153
|
|
|
$
|
(2,717
|
)
|
|
$
|
—
|
|
|
$
|
(1,672
|
)
|
|
$
|
(6,714
|
)
|
|
$
|
(7,043
|
)
|
Pre-tax income/(loss) from discontinued ops
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46,808
|
|
|
46,808
|
|
|
—
|
|
|
46,808
|
|
||||||||
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest expense
|
4,533
|
|
|
—
|
|
|
300
|
|
|
485
|
|
|
1,252
|
|
|
2,037
|
|
|
629
|
|
|
7,199
|
|
||||||||
Depreciation and amortization expenses
|
2,722
|
|
|
—
|
|
|
136
|
|
|
37
|
|
|
|
|
173
|
|
|
62
|
|
|
2,957
|
|
|||||||||
EBITDA
|
$
|
8,598
|
|
|
$
|
892
|
|
|
$
|
589
|
|
|
$
|
(2,195
|
)
|
|
$
|
48,060
|
|
|
$
|
47,346
|
|
|
$
|
(6,023
|
)
|
|
$
|
49,921
|
|
EBITDA adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Asset-specific debt interest
(2)
|
(1,309
|
)
|
|
—
|
|
|
(300
|
)
|
|
(485
|
)
|
|
(1,252
|
)
|
|
(2,037
|
)
|
|
—
|
|
|
(3,346
|
)
|
||||||||
Effects of purchase accounting
(3)
|
(248
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(248
|
)
|
||||||||
Non-cash fair value adjustments
(4)
|
66
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40,672
|
)
|
|
(40,672
|
)
|
|
—
|
|
|
(40,606
|
)
|
||||||||
Non-recurring expenses
(5)
|
1,086
|
|
|
—
|
|
|
—
|
|
|
868
|
|
|
—
|
|
|
868
|
|
|
(2,331
|
)
|
|
(377
|
)
|
||||||||
Adjusted EBITDA
|
$
|
8,193
|
|
|
$
|
892
|
|
|
$
|
289
|
|
|
$
|
(1,812
|
)
|
|
$
|
6,136
|
|
|
$
|
5,505
|
|
|
$
|
(8,354
|
)
|
|
$
|
5,344
|
|
Plus: Stock based compensation expense
|
627
|
|
|
—
|
|
|
20
|
|
|
—
|
|
|
—
|
|
|
20
|
|
|
585
|
|
|
1,232
|
|
||||||||
Less: Realized and unrealized gains (losses)
(6)
|
(4,499
|
)
|
|
(28
|
)
|
|
—
|
|
|
(3,178
|
)
|
|
5,512
|
|
|
2,306
|
|
|
—
|
|
|
(2,193
|
)
|
||||||||
Less: Third party NCI Adjusted EBITDA
|
—
|
|
|
—
|
|
|
—
|
|
|
(128
|
)
|
|
—
|
|
|
(128
|
)
|
|
—
|
|
|
(128
|
)
|
||||||||
Normalized EBITDA
|
$
|
13,319
|
|
|
$
|
920
|
|
|
$
|
309
|
|
|
$
|
1,494
|
|
|
$
|
624
|
|
|
$
|
3,347
|
|
|
$
|
(7,769
|
)
|
|
$
|
8,897
|
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||||||||||||||
|
|
|
Tiptree Capital
|
|
|
|
|
||||||||||||||||||||||||
($ in thousands)
|
Specialty insurance
|
|
Asset Management
|
|
Mortgage
|
|
Other
|
|
Discontinued Operations
(1)
|
|
Tiptree Capital
|
|
Corporate Expenses
|
|
Total
|
||||||||||||||||
Pre-tax income/(loss) from continuing ops
|
$
|
4,801
|
|
|
$
|
5,581
|
|
|
$
|
301
|
|
|
$
|
84
|
|
|
$
|
—
|
|
|
$
|
5,966
|
|
|
$
|
(6,729
|
)
|
|
$
|
4,038
|
|
Pre-tax income/(loss) from discontinued ops
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,530
|
)
|
|
(1,530
|
)
|
|
—
|
|
|
(1,530
|
)
|
||||||||
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest expense
|
3,445
|
|
|
—
|
|
|
216
|
|
|
1,137
|
|
|
2,701
|
|
|
4,054
|
|
|
1,280
|
|
|
8,779
|
|
||||||||
Depreciation and amortization expenses
|
3,294
|
|
|
—
|
|
|
138
|
|
|
60
|
|
|
4,255
|
|
|
4,453
|
|
|
62
|
|
|
7,809
|
|
||||||||
EBITDA
|
$
|
11,540
|
|
|
$
|
5,581
|
|
|
$
|
655
|
|
|
$
|
1,281
|
|
|
$
|
5,426
|
|
|
$
|
12,943
|
|
|
$
|
(5,387
|
)
|
|
$
|
19,096
|
|
EBITDA adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Asset-specific debt interest
(2)
|
(1,810
|
)
|
|
—
|
|
|
(216
|
)
|
|
(1,137
|
)
|
|
(2,701
|
)
|
|
(4,054
|
)
|
|
—
|
|
|
(5,864
|
)
|
||||||||
Effects of purchase accounting
(3)
|
(464
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(464
|
)
|
||||||||
Non-cash fair value adjustments
(4)
|
113
|
|
|
—
|
|
|
400
|
|
|
—
|
|
|
—
|
|
|
400
|
|
|
—
|
|
|
513
|
|
||||||||
Non-recurring expenses
(5)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
241
|
|
|
241
|
|
|
(1,736
|
)
|
|
(1,495
|
)
|
||||||||
Adjusted EBITDA
|
$
|
9,379
|
|
|
$
|
5,581
|
|
|
$
|
839
|
|
|
$
|
144
|
|
|
$
|
2,966
|
|
|
$
|
9,530
|
|
|
$
|
(7,123
|
)
|
|
$
|
11,786
|
|
Plus: Stock based compensation expense
|
1,351
|
|
|
—
|
|
|
49
|
|
|
—
|
|
|
—
|
|
|
49
|
|
|
399
|
|
|
1,799
|
|
||||||||
Less: Realized and unrealized gains (losses)
(6)
|
(1,528
|
)
|
|
2,233
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
2,229
|
|
|
—
|
|
|
701
|
|
||||||||
Less: Third party NCI Adjusted EBITDA
|
—
|
|
|
—
|
|
|
—
|
|
|
129
|
|
|
386
|
|
|
515
|
|
|
—
|
|
|
515
|
|
||||||||
Normalized EBITDA
|
$
|
12,258
|
|
|
$
|
3,348
|
|
|
$
|
888
|
|
|
$
|
19
|
|
|
$
|
2,580
|
|
|
$
|
6,835
|
|
|
$
|
(6,724
|
)
|
|
$
|
12,369
|
|
($ in thousands, except per share information)
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Total stockholders’ equity
|
$
|
407,660
|
|
|
$
|
393,838
|
|
Less non-controlling interest - other
|
5,430
|
|
|
22,970
|
|
||
Total stockholders’ equity, net of non-controlling interests - other
|
$
|
402,230
|
|
|
$
|
370,868
|
|
Total Class A shares outstanding
(1)
|
29,922
|
|
|
28,492
|
|
||
Total Class B shares outstanding
|
8,049
|
|
|
8,049
|
|
||
Total shares outstanding
|
37,971
|
|
|
36,541
|
|
||
Book value per share, as exchanged
|
$
|
10.59
|
|
|
$
|
10.15
|
|
($ in thousands)
|
Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
Total stockholders’ equity
|
$
|
407,660
|
|
|
$
|
393,838
|
|
Less non-controlling interest - other
|
5,430
|
|
|
22,970
|
|
||
Total stockholders’ equity, net of non-controlling interests - other
|
$
|
402,230
|
|
|
$
|
370,868
|
|
Plus Specialty Insurance accumulated depreciation and amortization, net of tax
|
37,599
|
|
|
30,491
|
|
||
Plus Care accumulated depreciation and amortization - discontinued operations, net of tax and NCI
|
—
|
|
|
23,965
|
|
||
Plus acquisition costs
|
4,161
|
|
|
7,563
|
|
||
Invested Capital
|
$
|
443,990
|
|
|
$
|
432,887
|
|
Plus corporate debt
|
$
|
188,000
|
|
|
$
|
205,626
|
|
Total Capital
|
$
|
631,990
|
|
|
$
|
638,513
|
|